Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 7;12(12):2019.
doi: 10.3390/jpm12122019.

Suicide Risk in Post-COVID-19 Syndrome

Alessio Simonetti  1   2 , Evelina Bernardi  2 , Delfina Janiri  1   3 , Marianna Mazza  2 , Silvia Montanari  2 , Antonello Catinari  2 , Beatrice Terenzi  2 , Matteo Tosato  4   5 , Vincenzo Galluzzo  5 , Francesca Ciciarello  5 , Francesco Landi  4   5 , Gabriele Sani  2   6
Affiliations

Suicide Risk in Post-COVID-19 Syndrome

Alessio Simonetti et al. J Pers Med. .

Abstract

Post-acute sequelae of COVID-19 include several neuropsychiatric disorders. Little is known about the relationship between post-COVID-19 syndrome and suicidality. The aim of the study was to investigate the risk of suicide in subjects with persistent post-COVID-19 syndrome. One-thousand five-hundred eighty-eight subjects were assessed in the Post-Acute Care Service at the Fondazione Policlinico Universitario "Agostino Gemelli" IRCCS of Rome. Assessment included: (a) sociodemographic characteristics; (b) symptoms during and after COVID-19; (c) psychopathological evaluation. Participants were divided in those with (SUI) or without (NON SUI) suicide risk according to the Mini International Neuropsychiatric Interview. Additionally, subjects with SUI were split into those with high (HIGH SUI) and low (LOW SUI) suicide risk. Between-group comparisons were made with t-tests for continuous variables and χ2 tests for categorical variables. SUI showed greater percentages of physical complaints during and after COVID-19, greater percentages of psychiatric history and presence of psychiatric history in relatives, greater percentages of subjects previously undergoing psychopharmacotherapy, and greater levels of anxiety, mixed depressive symptoms, general psychopathology than NON SUI. HIGH SUI showed greater number of symptoms during and after COVID-19 and higher levels of mixed depressive symptoms than LOW SUI. Percentages of subjects undergoing psychotherapy was higher in LOW SUI than HIGH SUI. Greater levels of physical complaints and psychopathology during post-COVID-syndrome might enhance the risk of committing suicide. Treatment of physical complaints and psychotherapy might reduce suicide risk.

Keywords: COVID-19; depression; post-COVID-19 syndrome; psychopathology; suicide.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Lu H., Stratton C.W., Tang Y.W. Outbreak of Pneumonia of Unknown Etiology in Wuhan, China: The Mystery and the Miracle. J. Med. Virol. 2020;92:401–402. doi: 10.1002/jmv.25678. - DOI - PMC - PubMed
    1. Brown E.E., Kumar S., Rajji T.K., Pollock B.G., Mulsant B.H. Anticipating and Mitigating the Impact of the COVID-19 Pandemic on Alzheimer’s Disease and Related Dementias. Am. J. Geriatr. Psychiatry. 2020;28:712–721. doi: 10.1016/j.jagp.2020.04.010. - DOI - PMC - PubMed
    1. Chilamakuri R., Agarwal S. COVID-19: Characteristics and Therapeutics. Cells. 2021;10:206. doi: 10.3390/cells10020206. - DOI - PMC - PubMed
    1. Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-Acute COVID-19 Syndrome. Nat. Med. 2021;27:601–615. doi: 10.1038/s41591-021-01283-z. - DOI - PMC - PubMed
    1. Mehandru S., Merad M. Pathological Sequelae of Long-Haul COVID. Nat. Immunol. 2022;23:194–202. doi: 10.1038/s41590-021-01104-y. - DOI - PMC - PubMed

LinkOut - more resources